Andrea Stutz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrea Stutz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Bernardo S. Franklin
Institute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany
1 shared publicationCarl-Christian Kolbe
Institute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany
1 shared publication- Eicke Latz
Institute of Innate Immunity, University of Bonn, Bonn, Germany
1 shared publication - Felix Meissner
Institute of Innate Immunity, Department for Systems Immunology and Proteomics, Medical Faculty, University of Bonn, Bonn, Germany
1 shared publication - Gábor Horváth
Institute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany
1 shared publication - Matthias Geyer
Institute of Structural Biology, Medical Faculty, University of Bonn, Bonn, Germany
1 shared publication
Latest Publications
- Open Access
- 2 May 2017
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 214 (6) , 1725-1736
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
NLRP3 is a cytosolic pattern recognition receptor that senses microbes and endogenous danger signals. Upon activation, NLRP3 forms an inflammasome with the adapter ASC, resulting in caspase-1 activation, release of proinflammatory cytokines and cell death. How NLRP3 activation is regulated by transcriptional and posttranslational mechanisms to prevent aberrant activation remains incompletely understood. Here, we identify three conserved phosphorylation sites in NLRP3 and demonstrate that NLRP3 activation is controlled by phosphorylation of its pyrin domain (PYD). Phosphomimetic residues in NLRP3 PYD abrogate inflammasome activation and structural modeling indicates that phosphorylation of the PYD regulates charge–charge interaction between two PYDs that are essential for NLRP3 activation. Phosphatase 2A (PP2A) inhibition or knock-down drastically reduces NLRP3 activation, showing that PP2A can license inflammasome assembly via dephosphorylating NLRP3 PYD. These results propose that the balance between kinases and phosphatases acting on the NLRP3 PYD is critical for NLRP3 activation.
- 2 May 2017
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 214 (6) , 1725-1736
Open AccessNLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
NLRP3 is a cytosolic pattern recognition receptor that senses microbes and endogenous danger signals. Upon activation, NLRP3 forms an inflammasome with the adapter ASC, resulting in caspase-1 activation, release of proinflammatory cytokines and cell death. How NLRP3 activation is regulated by transcriptional and posttranslational mechanisms to prevent aberrant activation remains incompletely understood. Here, we identify three conserved phosphorylation sites in NLRP3 and demonstrate that NLRP3 activation is controlled by phosphorylation of its pyrin domain (PYD). Phosphomimetic residues in NLRP3 PYD abrogate inflammasome activation and structural modeling indicates that phosphorylation of the PYD regulates charge–charge interaction between two PYDs that are essential for NLRP3 activation. Phosphatase 2A (PP2A) inhibition or knock-down drastically reduces NLRP3 activation, showing that PP2A can license inflammasome assembly via dephosphorylating NLRP3 PYD. These results propose that the balance between kinases and phosphatases acting on the NLRP3 PYD is critical for NLRP3 activation.